LEASE EXPANSION AND MODIFICATION AGREEMENTLease Expansion and Modification Agreement • May 7th, 2020 • Zymeworks Inc. • Pharmaceutical preparations
IN CONSIDERATION of the sum of Ten Dollars ($10.00) now paid by each of the parties to one another and for other good and valuable consideration (the receipt and sufficiency of which is acknowledged) and in consideration of the mutual covenants and agreements, the parties agree as follows:
CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT HAS BEEN OMITTED BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) WOULD LIKELY CAUSE COMPETITIVE HARM TO ZYMEWORKS INC. IF PUBLICLY DISCLOSED. INFORMATION THAT HAS BEEN OMITTED HAS BEEN NOTED IN...Collaboration Agreement • May 7th, 2020 • Zymeworks Inc. • Pharmaceutical preparations • New York
This Second Amendment (the “Amendment”) to the Agreement (as defined below), is entered into as of March 31, 2020 (the “Amendment Effective Date”), by and between CELGENE CORPORATION, a corporation organized and existing under the laws of Delaware, with its principal business office located at 86 Morris Avenue, Summit, NJ 07901, USA (“Celgene Corp.”), CELGENE ALPINE INVESTMENT CO. LLC (“Celgene Alpine” and, together with Celgene Corp., “Celgene”) and ZYMEWORKS INC., a corporation organized and existing under the laws of Canada, and extra provincially in British Columbia, having an address at 540-1385 West 8th Avenue, Vancouver, BC, Canada V6H 3V9 (“Zymeworks”). Zymeworks and Celgene are each referred to individually as a “Party” and together as the “Parties”.
